Levofloxacin in Bacterial Rhinosinussitis
Launched by DR. REDDY'S LABORATORIES LIMITED · Mar 14, 2016
Trial Information
Current as of May 22, 2025
Completed
Keywords
ClinConnect Summary
Inflammatory diseases of paranasal sinuses occupy one of the leading positions in the overall structure of ENT-diseases.
Puncture method has been a conventional approach to the treatment of suppurative maxillary sinusitis in Russia until present. However, this relatively simple and conventional treatment method has a number of disadvantages. Fear of an unpleasant procedure is justified. Generally, single puncture does not ensure healing, and the doctor has to install drainage or of perform repeated manipulations significantly reducing quality of life during the disease period. There is als...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Signed informed consent form.
- • Males and females aged 18-60 years old
- • Hospitalized subjects with verified diagnosis of moderate/severe acute bacterial rhinosinusitis
- • Readiness to comply with medical recommendations.
- • Assessment of objective and subjective symptoms of the disease \>= 3 points
- Exclusion Criteria:
- • Previous nasal surgery within the last 6 months
- • Participation in other studies
- • Polypous rhinosinusitis
- • Concomitant therapy affecting the study results (psychotropic drugs, alpha-adrenoreceptor antagonists, antihistamine drug, antibiotics, cromones, corticosteroids) within the last month
- • Need in cromones, antihistamine drugs, corticosteroids (moderate and severe allergic rhinitis)
- • Severe somatic diseases in the past medical history: severe endocrine pathologies, severe cardiovascular diseases, renal and/or hepatic failure, oncology
- • Subject's inability to perceive instructions for the study procedure
- • Pregnancy, lactation
- • Signs of a dangerous infectious disease.
About Dr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories Limited is a global pharmaceutical company headquartered in Hyderabad, India, dedicated to providing accessible and affordable healthcare solutions. With a strong focus on innovation, the company specializes in the development, manufacturing, and marketing of a wide range of pharmaceutical products, including generics, branded formulations, and active pharmaceutical ingredients (APIs). Dr. Reddy's is committed to advancing clinical research and development, fostering collaborations that enhance therapeutic options and improve patient outcomes worldwide. Through its rigorous clinical trials and adherence to regulatory standards, the company aims to deliver high-quality medicines that meet the needs of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
A Y Ovchinnikov
Principal Investigator
Head of the Department Diseases of the ear, nose and throat ,Moscow State Medical Dental University of the Ministry of Health of Russia, Otorhinolaryngology Department of Postgraduate Studies Faculty
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials